Suhas V Vasaikar
Overview
Explore the profile of Suhas V Vasaikar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
2058
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lei J, Dobrolecki L, Huang C, Srinivasan R, Vasaikar S, Lewis A, et al.
bioRxiv
. 2024 Dec;
PMID: 39713418
Combination chemotherapy remains essential for clinical management of triple-negative breast cancer (TNBC). Consequently, responses to multiple single agents cannot be delineated at the single patient level, even though some patients...
2.
Thomson Z, He Z, Swanson E, Henderson K, Phalen C, Zaim S, et al.
Nat Immunol
. 2024 Jan;
25(3):577.
PMID: 38267693
No abstract available.
3.
Thomson Z, He Z, Swanson E, Henderson K, Phalen C, Zaim S, et al.
Nat Immunol
. 2023 Oct;
24(11):1947-1959.
PMID: 37845489
Age-associated changes in the T cell compartment are well described. However, limitations of current single-modal or bimodal single-cell assays, including flow cytometry, RNA-seq (RNA sequencing) and CITE-seq (cellular indexing of...
4.
Talla A, Vasaikar S, Szeto G, Lemos M, Czartoski J, MacMillan H, et al.
Nat Commun
. 2023 Jun;
14(1):3417.
PMID: 37296110
Long COVID or post-acute sequelae of SARS-CoV-2 (PASC) is a clinical syndrome featuring diverse symptoms that can persist for months following acute SARS-CoV-2 infection. The aetiologies may include persistent inflammation,...
5.
Vasaikar S, Savage A, Gong Q, Swanson E, Talla A, Lord C, et al.
Nat Commun
. 2023 Mar;
14(1):1684.
PMID: 36973282
Longitudinal bulk and single-cell omics data is increasingly generated for biological and clinical research but is challenging to analyze due to its many intrinsic types of variations. We present PALMO...
6.
Satpathy S, Krug K, Jean Beltran P, Savage S, Petralia F, Kumar-Sinha C, et al.
Cell
. 2021 Aug;
184(16):4348-4371.e40.
PMID: 34358469
Lung squamous cell carcinoma (LSCC) remains a leading cause of cancer death with few therapeutic options. We characterized the proteogenomic landscape of LSCC, providing a deeper exposition of LSCC biology...
7.
Talla A, Vasaikar S, Lemos M, Moodie Z, Lee Pebworth M, Henderson K, et al.
bioRxiv
. 2021 Jun;
PMID: 34075380
SARS-CoV-2 has infected over 200 million and caused more than 4 million deaths to date. Most individuals (>80%) have mild symptoms and recover in the outpatient setting, but detailed studies...
8.
Deshmukh A, Vasaikar S, Tomczak K, Tripathi S, den Hollander P, Arslan E, et al.
Proc Natl Acad Sci U S A
. 2021 May;
118(19).
PMID: 33941680
The epithelial-to-mesenchymal transition (EMT) plays a critical role during normal development and in cancer progression. EMT is induced by various signaling pathways, including TGF-β, BMP, Wnt-β-catenin, NOTCH, Shh, and receptor...
9.
EMTome: a resource for pan-cancer analysis of epithelial-mesenchymal transition genes and signatures
Vasaikar S, Deshmukh A, den Hollander P, Addanki S, Kuburich N, Kudaravalli S, et al.
Br J Cancer
. 2020 Dec;
124(1):259-269.
PMID: 33299129
Background: The epithelial-mesenchymal transition (EMT) enables dissociation of tumour cells from the primary tumour mass, invasion through the extracellular matrix, intravasation into blood vessels and colonisation of distant organs. Cells...
10.
Gillette M, Satpathy S, Cao S, Dhanasekaran S, Vasaikar S, Krug K, et al.
Cell
. 2020 Jul;
182(1):200-225.e35.
PMID: 32649874
To explore the biology of lung adenocarcinoma (LUAD) and identify new therapeutic opportunities, we performed comprehensive proteogenomic characterization of 110 tumors and 101 matched normal adjacent tissues (NATs) incorporating genomics,...